ACRO Biomedical Co

ACRO Biomedical Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ACRO Biomedical Co (6748.TWO) as of Nov 11, 2026 is -92.89 M TWD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -64.15 M TWD — a change of 44.78% (lower).

EBITDA

-92.89 MTWD

YoY

44.78%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ACRO Biomedical Co is 2025 -92.89 M TWD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ACRO Biomedical Co was 2024 -64.15 M TWD. It decreases by 44.78% lower compared to the previous year.

The ACRO Biomedical Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-44.79 M TWD
Jan 1, 2020
-55.32 M TWD
Jan 1, 2021
-52.80 M TWD
Jan 1, 2022
-61.12 M TWD
Jan 1, 2023
-46.69 M TWD
Jan 1, 2024
-64.15 M TWD
Jan 1, 2025
-92.89 M TWD
The ACRO Biomedical Co EBITDA history
YEAREBITDAYoY
-92.89 MTWD+44.78%
-64.15 MTWD+37.40%
-46.69 MTWD-23.60%
-61.12 MTWD+15.76%
-52.80 MTWD-4.56%
-55.32 MTWD+23.50%
-44.79 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

ACRO Biomedical Co Stock analysis

What does ACRO Biomedical Co do? ACRO Biomedical Co., Ltd. generates revenue through the development and production of biomaterial medical devices, primarily focusing on collagen scaffolds for tissue engineering and regenerative medicine. The company offers products such as ABCcolla Collagen Bone Graft, ABCcolla Collagen Matrix, ABCcolla Collagen Matrix Powder, ABCcolla Scar Spray, and ABCcolla External Aesthetic Restoration Prosthesis, all derived from pig skin and pig bone. These products are sold to healthcare providers and medical institutions involved in tissue engineering and regenerative medicine procedures. The firm also engages in international trade and technical services related to its products, expanding its market reach beyond local healthcare sectors. The company's revenue streams are driven by the sale of its specialized collagen-based medical devices, which are designed for applications in tissue repair and aesthetic restoration. ABCcolla Collagen Bone Graft targets bone regeneration, while ABCcolla Collagen Matrix and its variants support soft tissue engineering. ABCcolla Scar Spray addresses scar management, and the External Aesthetic Restoration Prosthesis serves cosmetic and reconstructive needs. These products cater to medical professionals seeking advanced solutions in regenerative medicine. ACRO Biomedical's business model relies on direct sales to healthcare institutions and international trade channels. The firm's focus on pig-derived collagen products positions it as a supplier for tissue engineering applications, with a strong emphasis on regenerative medicine. Technical services complement product sales, enhancing customer retention and recurring revenue opportunities. The company's product portfolio is tailored to meet the specific demands of medical professionals in tissue repair and aesthetic restoration markets. ACRO Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ACRO Biomedical Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ACRO Biomedical Co is -92.89 M TWD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of ACRO Biomedical Co changed from -64.15 M TWD to -92.89 M TWD, representing a 44.78% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) ACRO Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s ACRO Biomedical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — ACRO Biomedical Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — ACRO Biomedical Co